© Copyright - Newspaper WordPress Theme by TagDiv
Ivermectin
Also known as / Synonyms: Ivermectin, MK-0933, Avermectin Derivative
Anthelmintic and antiparasitic medication used as a single oral dose for strongyloidiasis, onchocerciasis, and resistant scabies.
Clinical Snapshot & Specifications
Approved Indications & Medical Uses
- Treatment of strongyloidiasis of the intestinal tract caused by the nematode Strongyloides stercoralis.
- Treatment of onchocerciasis (river blindness) caused by Onchocerca volvulus.
- Treatment of crusted (Norwegian) scabies and recalcitrant human scabies (in conjunction with topical scabicides).
- Treatment of cutaneous larva migrans and filariasis (in combination with albendazole).
- Topical treatment of inflammatory lesions of rosacea.
Contraindications (Do Not Use If…)
- Known hypersensitivity to ivermectin or any tablet excipients.
- Conditions associated with an impaired blood-brain barrier (such as human African trypanosomiasis or meningitis) due to potential CNS neurotoxicity.
Important Clinical Precautions & Warnings
- Take on an empty stomach: oral absorption is maximized when taken with water on an empty stomach at least 1 hour before or 2 hours after meals.
- Mazzotti reaction in onchocerciasis: acute inflammatory response (fever, pruritus, rash, arthralgia, lymphadenopathy, tachycardia, hypotension) caused by death of microfilariae; corticosteroids or antihistamines may be indicated.
- Co-infection with Loa loa: patients with high Loa loa microfilarial loads are at risk of severe encephalopathy and fatal cerebral reactions; assess loiasis risk in endemic regions.
- Immunocompromised patients: patients with HIV or hyperinfection strongyloidiasis may require repeated courses of ivermectin therapy.
Special Populations (Paediatric & Geriatric Care)
Pediatric: Safety and efficacy have not been established in pediatric patients weighing less than 15 kg. Geriatric: No specific dose adjustments required; monitor liver and renal function.
Side Effects & Adverse Reactions
Common Side Effects (Usually Mild)
Dizziness, pruritus, skin rash, nausea, diarrhea, asthenia, muscle aches, and somnolence.
Serious Side Effects — Seek Urgent Medical Care
Severe Mazzotti-type systemic inflammatory reactions, encephalopathy and coma (in severe Loa loa co-infection), exfoliative dermatitis, and severe orthostatic hypotension.
Action: Discontinue medication and seek immediate medical attention or call emergency services if any serious symptom occurs.
Drug, Food & Substance Interactions
- Warfarin: postmarketing cases of increased international normalized ratio (INR) have been reported; monitor INR when co-administered.
- GABA-enhancing drugs (barbiturates, benzodiazepines, valproate): theoretically may potentiate central GABAergic effects, although systemic ivermectin does not readily cross an intact blood-brain barrier.
- P-glycoprotein inhibitors: may increase brain penetration of ivermectin.
Pregnancy & Lactation Clinical Safety
Pregnancy Safety:
Use with caution — see notesIvermectin has shown teratogenicity (cleft palate) in animal studies at maternally toxic doses. Adequate human studies in pregnancy are lacking. Treatment of onchocerciasis or strongyloidiasis in pregnant women should generally be deferred until after delivery, unless life-threatening.
Lactation & Breastfeeding:
Use with caution — see notesIvermectin is excreted in human milk in low concentrations (< 2% of maternal dose). Safety in newborn infants has not been established. Wait until child is at least 1 week old or defer until weaning when possible.
Storage, Administration & Overdose Protocol
🌡️ Recommended Storage:
Store tablets below 30°C (86°F). Protect from excessive heat and direct sunlight.
⏱️ Missed Dose Protocol:
Most indications require a single oral dose. If prescribed a repeat dose (e.g., at day 8 or 14 for crusted scabies) and missed, take on an empty stomach as soon as remembered.
Overdose produces profound neurotoxicity: ataxia, paresthesia, tremors, seizures, somnolence, stupor, and respiratory arrest. Supportive care in an intensive care setting with airway support and IV fluids is required.
